Добавил:
Upload Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Practical Plastic Surgery

.pdf
Скачиваний:
188
Добавлен:
10.02.2016
Размер:
11.54 Mб
Скачать

112 Practical Plastic Surgery

Table 20.1. Options for flap coverage of the groin

Flap

Pedicle

Advantages

Disadvantages

Sartorius

Branches from the

Easy harvest

SFA occlusion common

 

superficial femoral

Minimal

in vasculopathies

 

artery (inferior/

donor site

Limited arc of rotation

 

minor pedicle)

 

Proximity to infected

 

 

 

tissue

Gracilis

Medial circumflex

Minimal

More difficult harvest

 

femoral, profunda

donor site

 

 

femoris

 

 

Rectus

Lateral circumflex

Easy harvest

May weaken extension

femoris

femoral, profunda

Bulky flap

at the knee

 

femoris

Skin may be

 

 

 

transferred

 

Rectus

Deep inferior

Wide arc

May develop ventral

abdominis

epigastric,

of rotation

hernia at the donor site

 

external iliac

 

DIEA occlusion is

 

 

 

common

The senior author has described an extended approach to the gracilis, which can also be used successfully. It is approached through an overlying medial thigh incision. If a recent saphenectomy has been performed, this incision may be used. After medial reflection of the adductor longus, the gracilis is identified by the absence of nerves around the muscle, the lack of attachments deep and superficial to the muscle, and tapering of the muscle as it dissection proceeds down the thigh.

20The dominant pedicle is identified on the deep medial aspect of the muscle. The insertion of the gracilis to the femur is divided distally, and the minor segmental pedicles are ligated, as are small vessels from the dominant pedicle that supply the overlying adductor longus. The origin of the gracilis at the pubic symphysis is then divided and the muscle is tunneled beneath the adductor into the femoral triangle. Drains are placed in the donor site and beneath the flap if possible.

The use of the rectus femoris is another option. This flap is reached through a midline thigh incision. The tendon is divided 4 cm from the patella. The distal minor pedicle is ligated, and the flap can be folded up into the wound. The rectus abdominis has also been used successfully in this setting. Finally, the ipsilateral or contralateral rectus muscle can be used for coverage of the groin when the profunda femoris vascular pedicle is compromised. Intraoperatively, blood flow to the flap should be confirmed with a handheld Doppler, before it is elevated.

Postoperative Considerations

Intravenous antibiotics should be administered based on intraoperative culture results. Some authors have suggested that therapy be continued for six weeks in the case of autogenous grafts and up to one year for prosthetic grafts. Lifelong suppressive doses of oral antibiotics should be considered in the latter group.

Infected Prosthetic Hemodialysis Grafts

Although exposed dialysis grafts have traditionally been removed, the paucity of vascular access sites in long-term hemodialysis patients has led to several successful strategies to salvage them. In contrast to the bypass grafts described above, dialysis

Infected and Exposed Vascular Grafts

113

 

 

grafts are not acutely imperative to life or limb. As in arterial bypass grafts, hemor-

 

 

rhage or systemic infection mandates total graft excision. Since such grafts have a

 

 

lifespan that averages 2-3 years, simple local flaps are typically used. Flaps such as

 

 

the flexor carpi ulnaris and lateral arm flap allow coverage in the proximal forearm.

 

 

The radial artery island fasciocutaneous flap, meanwhile, may provide coverage to

 

 

the mid and distal forearm. Random pattern flaps should be used with caution, as

 

 

they do not provide as reliable coverage. Vascular puncture can usually be continued

 

 

during healing.

 

 

 

Pearls and Pitfalls

 

 

 

Patients with infected or exposed vascular grafts are in the highest risk group for

 

 

subsequent wound complications. They have already demonstrated wound healing

 

 

problems from their initial surgery. Their vascularity and wound healing is compro-

 

 

mised due to their underlying peripheral vascular disease. Many of these patients are

 

 

also renal failure patients and malnourished.

 

 

 

In considering the coverage procedure, one should expect donor site complica-

 

 

tions ahead of time. The donor site should be distant from the graft site and away

 

 

from important structures. For example, harvesting a sartorius flap for coverage of a

 

 

groin bypass graft may not be wise if the donor site is in close proximity to the

 

 

infected wound. In regards to the exposed graft, muscle coverage should be placed

 

 

transversely over a longitudinal graft, so that if the coverage breaks down, only a

 

 

small area of graft will be exposed. In addition, the graft should be covered in stag-

 

 

gered layers by closing the muscle and skin layers separately without the skin inci-

 

 

sion lying directly over the muscle incision.

 

 

 

Suggested Reading

 

 

 

1. Morasch MD, Sam IInd AD, Kibbe MR et al. Early results with use of gracilis muscle

 

20

flap coverage of infected groin wounds after vascular surgery. J Vasc Surg 2004;

 

 

 

 

39(6):1277-83.

 

 

 

2.Alkon JD, Smith A, Losee JE et al. Management of complex groin wounds: Preferred use of the rectus femoris muscle flap. Plast Reconstr Surg 2005; 115(3):776-83.

Chapter 21

Management of Exposed

and Infected Orthopedic Prostheses

Mark Sisco and Michael A. Howard

Background

Wound dehiscence and periprosthetic infections complicating orthopedic implants are a significant source of postoperative morbidity that may be limb, or life-threatening. While the treatment of superficial wound complications is relatively straightforward, there is less agreement in the literature about the correct course of action when an implant itself is exposed or infected. Several authors advocate the traditional approach, which consists of removal of all exposed or infected implants with delayed flap closure. This approach tends to result in prolonged hospitalization and significant functional loss. Several recent reports suggest that early debridement with definitive muscle flap coverage may make it possible to salvage prostheses in select patients. The plastic surgeon is often consulted after the orthopedic surgeon has determined that the wound cannot be closed primarily or that the implant is infected. The cornerstones of prosthesis salvage include:

1.Early identification of infection

2.Aggressive debridement

3.Appropriate antibiotic therapy

4.Prompt soft-tissue coverage

All options in the reconstructive ladder may be needed depending on the size of

the defect and the extent of the exposed structures.

Preoperative Considerations

Orthopedic patients are susceptible to wound complications for several reasons. Surgery may involve wide undermining of the soft tissues. Postoperative edema may be significant since joints have relatively poor lymphatic drainage, further compromised by surgery, leading to undue tension of the skin and incision. Prostheses may be positioned directly underneath the skin incision in an area that is poorly vascularized. Finally, many patients have had prior surgery, the scarring from which contributes to decreased tissue pliability and blood flow. In sum, the altered blood flow, increased edema and wound tension result in decreased oxygen delivery to the healing incision.

Persistent drainage or problematic wound healing has been described in up to 20% of total knee arthroplasty (TKA) patients, with an infection rate of 1-12%. The total incidence of infection following total hip arthroplasty (THA) is smaller: about 1%. When evaluating such problems, it is critical to distinguish wound infection from wound failure, since the treatment algorithms are different. Wound infection may cause wound failure. Wound failure, meanwhile, may cause implant

Practical Plastic Surgery, edited by Zol B. Kryger and Mark Sisco. ©2007 Landes Bioscience.

Management of Exposed and Infected Orthopedic Prosthesis

115

contamination and subsequent infection. The most common symptoms and signs of infection following TKA and THA are pain, erythema and purulent wound drainage. Additional laboratory tests such as a CBC, ESR, C-reactive protein and joint aspiration may also help to establish the diagnosis.

It is also important to consider the patient’s comorbidities. Factors that predispose to failure of implant salvage include: previous surgeries, diabetes, adjuvant radiation therapy, connective tissue disease, peripheral vascular disease, tobacco use, prior steroid treatments and rheumatic disease. Factors that predict successful implant salvage in the setting of infection include: <2 week duration of symptoms; susceptible gram positive organism (especially Streptococcus); lack of radiologic evidence of infection or loosening of the prosthesis; and absence of a sinus tract.

Operative and Postoperative Considerations

Open Wounds without Evidence of Infection

In the absence of infection, prostheses underlying open wounds are often salvageable, even when exposed. Immediate closure may be considered, provided that there are no signs of infection and well-vascularized tissue exists. Primary closure may be especially difficult due to the lack of mobile soft tissue adjacent to the wound. Wounds that do not involve exposed tendon, bone or joint may be treated with local wound care, negative pressure wound therapy followed by skin grafts, or fasciocutaneous flaps-depending on the size of the defect. Wounds in which the tendon, bone or joint are exposed should be treated with debridement, irrigation and flap reconstruction. Some of the more commonly used flaps are listed in Table 21.1.

Infections

The keys to initial management of wound infections are: identification of the anatomic extent of infection, aggressive debridement of devascularized tissue, thor- 21 ough irrigation, and culture-specific systemic antibiotic therapy. Thereafter, superfi-

cial infections may be managed with local wound care, skin grafts or fasciocutaneous flaps. Medium-depth infections, which extend to the joint capsule without involving the bone or joint structures, may be treated with skin grafts, fasciocutaneous flaps or muscle flaps depending on the size of the defect and, in the case of the knee, whether tendon is involved.

Deep infections that involve the bone or joint structures require more aggressive management. Acutely infected wounds should be thoroughly debrided, irrigated and

Table 21.1. A hierarchical list of flaps useful for treatment of exposed and infected artificial joints

Hip

Knee

Ankle

Vastus lateralis

Medial gastrocnemius

Free flap

Rectus femoris

Lateral gastrocnemius

Tibialis anterior

Rectus abdominis (inferior pedicle)

Fasciocutaneous flaps

Medial plantar

Gluteus medius

Free flap

 

Tensor fascia lata

 

 

Free flap

 

 

 

 

 

116

Practical Plastic Surgery

treated with broad spectrum, anti-staphylococcal antibiotics. Definitive surgical closure of the wound, often with muscle flaps, may be undertaken when signs of infection have abated, preferably within 7 days. Chronic infections (greater than 4 weeks) often require implant removal and placement of an antibiotic-impregnated spacer, followed by second-stage reimplantation after long-term IV antibiotic therapy. Patients who require implant removal are at increased risk of wound failure following prosthesis reimplantation due to inadequate local tissues and patient compromise. As such, a low threshold should be used for muscle flap coverage at the second stage.

Pearls and Pitfalls

Successful salvage of a threatened or exposed implant requires a good working relationship with the orthopedic surgeon and prompt evaluation and treatment of the patient. Serial debridements may be needed until the site is clean and all tissues are deemed viable. Final closure should proceed in an expeditious manner when the wound is deemed ready. The major pitfalls to success lie in both delaying treatment and conversely, rushing closure. If one adopts the “wait and see” attitude, a worsening picture may develop due to bacterial contamination and subsequent infection. Hurrying the closure before the wound is clean may result in the subsequent development of osteomyelitis.

Suggested Reading

1.Adam RF, Watson SB, Jarratt JW et al. Outcome after flap cover for exposed total knee arthroplasties. A report of 25 cases. J Bone Joint Surg Br 1994; 76(5):750-3.

2.Attinger CE, Ducic I, Cooper P et al. The role of intrinsic muscle flaps of the foot for bone coverage in foot and ankle defects in diabetic and nondiabetic patients. Plast Reconstr Surg 2002; 110(4):1047-54.

3.Browne Jr EZ, Stulberg BN, Sood R. The use of muscle flaps for salvage of failed total knee arthroplasty. Br J Plast Surg 1994; 47(1):42-5.

4.Burger RR, Basch T, Hopson CN. Implant salvage in infected total knee arthroplasty.

21Clin Orthop Relat Res 1991; (273):105-12.

5.Eckardt JJ, Lesavoy MA, Dubrow TJ et al. Exposed endoprosthesis. Management protocol using muscle and myocutaneous flap coverage. Clin Orthop Relat Res 1990; (251):220-9.

6.Gusenoff JA, Hungerford DS, Orlando JC et al. Outcome and management of infected wounds after total hip arthroplasty. Ann Plast Surg 2002; 49(6):587-92.

7.Jones NF, Eadie P, Johnson PC et al. Treatment of chronic infected hip arthroplasty wounds by radical debridement and obliteration with pedicled and free muscle flaps. Plast Reconstr Surg 1991; 88(1):95-101.

8.Markovich GD, Dorr LD, Klein NE et al. Muscle flaps in total knee arthroplasty. Clin Orthop Relat Res 1995; (321):122-30.

9.Nahabedian MY, Mont MA, Orlando JC et al. Operative management and outcome of complex wounds following total knee arthroplasty. Plast Reconstr Surg 1999; 104(6):1688-97.

10.Nahabedian MY, Orlando JC, Delanois RE et al. Salvage procedures for complex soft tissue defects of the knee. Clin Orthop Relat Res 1998; (356):119-24.

Chapter 22

Hypertrophic Scars and Keloids

Zol B. Kryger

Scar Definitions

An immature scar is red, slightly elevated and may be pruritic or tender. With time, it will usually become mature.

Amature scar is flat and usually slightly paler, but occasionally darker than the surrounding skin.

Alinear hypertrophic scar is red, raised and confined to the original borders of the incision. It usually occurs weeks after surgery and can continue to increase in size over the next few months. It will often become less raised with time.

Awidespread hypertrophic scar, such as a burn scar, is red, raised and confined to the original borders of injury.

Minor keloids are raised and usually pruritic. They extend beyond the borders of original injury, over the normal skin. They can develop up to a year post injury. They do not regress spontaneously, and if excised, usually return.

Major keloids are over 5 mm in diameter. They can be painful, and often will continue to spread over years. Keloids have a familial predilection. They are much more common in blacks and Asians than in whites.

Pathogenesis

Hypertrophic scarring and keloid formation are the result of excess collagen accumulation in a healing wound. The collagen is largely Type III, the form found in normal immature scars. Causes include excessive skin tension, wound infection, delayed healing, abnormal fibroblast metabolism, and an array of hereditary abnormalities. The importance of excess tension cannot be overemphasized. Hypertrophic scars tend to form in areas of high tension, such as the anterior chest and upper back. All measures for reducing tension on a healing scar should be employed.

The molecular mechanisms for pathological scarring are under intense investigation. Many studies have shown that levels of various cytokines are elevated in hypertrophic scars and keloids. For example, the transforming growth factor-beta (TGF-β) superfamily has been implicated in hypertrophic scarring. Other cytokines, such as tumor necrosis factor and interleukin-1, show decreased levels in keloids. Research is ongoing, and several active clinical trials are evaluating agents that inhibit or increase key mediators in the process of excessive scarring.

Surgical Excision

Surgery alone is not recommended for keloids due to the very high rate of recurrence (50-100%). It should be combined with additional treatment modalities such as steroid injection or silicone sheeting. For hypertrophic scars, excision alone may be indicated if it is felt that the abnormal scarring was due to excessive tension or

Practical Plastic Surgery, edited by Zol B. Kryger and Mark Sisco. ©2007 Landes Bioscience.

118

Practical Plastic Surgery

wound complications (e.g., infection or delayed healing). In such cases, excision should be accompanied by a measure to decrease tension. Splinting of the incision is most effectively accomplished by intradermal sutures left in place for 6 weeks to 6 months, depending on the degree of tension. Z-plasties and other techniques of reorienting the direction of tension can be used as well.

Silicone Gel Sheeting

This modality has become standard of care for the treatment of hypertrophic scars. It should be used as a first-line agent for linear hypertrophic scars. Numerous randomized, double-blind studies have shown that it is efficacious for treating hypertrophic scars and small keloids. The benefits of silicone sheeting have not been demonstrated with other types of semior total occlusive dressings. Since this treatment is painless, it is an excellent option for children or adults unwilling to tolerate more painful options. For prophylaxis in those at risk for hypertrophic scarring, treatment should begin a few days postoperatively. Silicone sheeting should be worn a minimum of 12 hours a day, and preferably the entire day. It should be continued for several weeks postoperatively.

Corticosteroid Injections

Years of clinical experience and many randomized, prospective trials have shown that triamcinolone injected into the scar is efficacious at decreasing scarring. Response rates range from 50-100%, with a recurrence rate of 10-50%. It should be the first-line therapy for keloids and second-line for hypertrophic scars. In combination with other therapies such as surgery and cryotherapy, corticosteroid injections can be even more effective. Side effects are common and include skin atrophy, telengiectasias and pigment changes. The exact mechanism by which steroids diminish scarring is still largely unknown. What has been shown is that topical steroids are not effective in reducing scarring.

22 Pressure Therapy

Compression is the first-line treatment for post-burn, widespread hypertrophic scars. In order to be effective, pressure must be maintained between 24-30 mm Hg for at least 6 months duration. The longer the treatment, the more efficacious pressure therapy has been shown to be.

Steri-Strips®

Adhesive microporous paper tape applied to fresh incisions for several weeks postoperatively is moderately useful in preventing hypertrophic scaring. The mechanism is not entirely clear. It is likely a combination of occlusion and splinting of the incision.

Radiation Therapy

Radiotherapy should be reserved for adults with keloids resistant to other treatment modalities. Monotherapy is controversial, and most authors recommend using it following surgical excision. Response rates range from 10-90% for radiotherapy alone, and in combination with surgery it is more likely to be effective. Recurrence is very common, ranging from 50-100%.

Hypertrophic Scars and Keloids

119

Cryotherapy

 

This modality has shown benefit in acne-induced scarring. It should not be used

 

for large scars. Side effects are common and include hypoor hyperpigmentation,

 

skin atrophy and pain.

 

Laser Treatment

 

Various lasers have been used in an attempt to treat hypertrophic scars and keloids,

 

and the results have been largely disappointing. The flashlamp-pumped pulsed-dye

 

laser appears promising, but more studies are needed. In combination with other

 

modalities, such as corticosteroid injection, it has been shown to be effective. Its

 

primary role is in reducing scar erythema and flattening mildly atrophic and hyper-

 

trophic scars. At this point, it is largely an emerging technology.

 

Other Emerging Therapies

 

A number of chemotherapeutic agents have demonstrated efficacy in treating

 

hypertrophic scarring and keloids. These include intralesional injections of inter-

 

feron, 5-fluorouracil, and bleomycin, as well as topical administration with retinoic

 

acid. Other emerging novel treatments focus on interfering with collagen synthesis

 

and the cytokines involved in scarring, such as inhibitors of TGF-β.

 

Summary

 

Hypertrophic scars and keloids can be a formidable problem. Many approaches

 

have been tried, but the recurrence rate is high for most treatments, especially for

 

keloids. Surgical excision should be followed by an additional preventative measure,

 

such as silicone gel sheeting. Ongoing research is attempting to pinpoint the mecha-

 

nisms for these pathologic processes in hopes of uncovering more effective therapies.

 

Pearls and Pitfalls

 

The recommended treatment modality for the various types of pathologic scars

22

is summarized in Table 22.1.

Table 22.1. Recommended treatment modality for various types of pathologic scars

Type of Scar

Recommended Management

Prophylaxis

Avoidance of infection and delayed healing; Steri-strips® for

 

occlusion; silicone sheeting

Immature

Follow closely and treat as a linear scar if it progresses;

hypertrophic scar

pulsed-dye laser for redness

Linear

Silicone gel sheeting; pressure garments and intralesional

hypertrophic scar

corticosteroid if it fails. Surgical excision with silicone

 

sheeting if 1 year of conservative management fails

Widespread

Pressure garments and silicone gel sheeting; massage

hypertrophic scar

and/or physical therapy can help

Minor keloids

Silicone sheeting combined with intralesional corticosteroids;

 

add surgical excision if these fail (use epidermis as a STSG);

 

add postoperative radiotherapy only for refractory cases

Major keloids

No consensus on treatment; radiation therapy or other

 

emerging modalities (e.g., 5-fluorouracil) should be attempted

120

Practical Plastic Surgery

Suggested Reading

1.Chang P, Laubenthal KN, Lewis IInd RW et al. Prospective, randomized study of the efficacy of pressure garment therapy in patients with burns. J Burn Care Rehabil 1995; 16:473.

2.Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol 1994; 30:506.

3.Mustoe TA, Cooter RD, Gold MH et al. International clinical recommendations on scar management. Plast Reconstr Surg 2002; 110:560.

4.Poston J. The use of silicone gel sheeting in the management of hypertrophic and keloid scars. J Wound Care 2000; 9:10.

5.Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: A comprehensive review. Plast Reconstr Surg 1989; 84:827.

6.Tang YW. Intraand postoperative steroid injections for keloids and hypertrophic scars. Br J Plast Surg 1992; 45:371

22

Chapter 23

Benign Skin Lesions

Zol B. Kryger

Introduction

Although this chapter deals with benign skin lesions, a number of these conditions are premalignant and must be regularly evaluated and biopsied if they become suspicious. The benign lesions and disorders of the skin are tremendously diverse and extensive. This chapter focuses on the common lesions encountered by the plastic surgeon. Since many patients arrive with the question, “is this cancer?” an attempt has been made to classify every lesion as benign or premalignant. Some common terminology used in describing disorders of the skin is listed in Table 23.1.

Lesions of the Epidermis

Seborrheic keratosis is a common lesion, particularly in the elderly on sun-exposed areas. Multiple lesions are usually present. It demonstrates variable pigmentation and its borders have a sharp, “pasted on” appearance, allowing it to be scraped off with a scalpel. Clinically, it may be confused with melanoma; pathologically, it appears similar to squamous cell carcinoma. It is benign and has no malignant potential, so shave excision or freezing is adequate.

Actinic (solar) keratosis is a dysplastic, premalignant lesion. Like the seborrheic keratosis, multiple lesions may present in sun-exposed areas. It appears as a scaling, poorly demarcated plaque. Suspicious sites should undergo excisional biopsy. Multiple solar keratoses may be treated with topical 5-fluorouracil.

Keratoacanthoma is a rapidly growing papule with a round, smooth, pink rim encircling a keratinous plug. It is premalignant, and some consider it to be a variant of squamous cell carcinoma. Diagnosis is made by excisional biopsy; treatment consists of wide local excision or injection with 5-fluorouracil. Occasionally, these lesions regress spontaneously.

Epithelial Cysts

Epithelial cysts, previously termed sebaceous cysts, are epithelium-lined cysts filled with a keratinous and lipid core. They are benign and have several forms:

Dermoid cysts are congenital cysts that usually occur along the midline or at the lateral end of the eyebrow. They represent developmental inclusion of the embryonic epidermis. Like the teratoma, their core may contain material from all three germinal cell layers (e.g., glandular material, hair follicle, cartilage, bone). Patients with midline lesions of the face should undergo computed tomography to check for intracranial extension. Treatment consists of excision.

Epidermoid cysts are firm, fluctuant nodules, often with a central comedo that represents an epithelial opening. They are variable in size. They contain a cheesy,

Practical Plastic Surgery, edited by Zol B. Kryger and Mark Sisco. ©2007 Landes Bioscience.

Соседние файлы в предмете [НЕСОРТИРОВАННОЕ]